KR970702723A - 베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections) - Google Patents

베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections)

Info

Publication number
KR970702723A
KR970702723A KR1019960706126A KR19960706126A KR970702723A KR 970702723 A KR970702723 A KR 970702723A KR 1019960706126 A KR1019960706126 A KR 1019960706126A KR 19960706126 A KR19960706126 A KR 19960706126A KR 970702723 A KR970702723 A KR 970702723A
Authority
KR
South Korea
Prior art keywords
beta
penem
combination
lactam antibiotic
treatment
Prior art date
Application number
KR1019960706126A
Other languages
English (en)
Other versions
KR100363604B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9408163A external-priority patent/GB9408163D0/en
Priority claimed from GB9408161A external-priority patent/GB9408161D0/en
Priority claimed from GB9408164A external-priority patent/GB9408164D0/en
Priority claimed from GB9408162A external-priority patent/GB9408162D0/en
Application filed filed Critical
Publication of KR970702723A publication Critical patent/KR970702723A/ko
Application granted granted Critical
Publication of KR100363604B1 publication Critical patent/KR100363604B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019960706126A 1994-04-25 1995-04-22 베타-락탐항생물질과함께베타-락타마제억제페넴을함유하는약제제형및이것의세균감염의치료에서의용도 KR100363604B1 (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9408161.9 1994-04-25
GB9408164.3 1994-04-25
GB9408162.7 1994-04-25
GB9408163A GB9408163D0 (en) 1994-04-25 1994-04-25 Pharmaceutical formulations
GB9408161A GB9408161D0 (en) 1994-04-25 1994-04-25 Pharmaceutical formulations
GB9408164A GB9408164D0 (en) 1994-04-25 1994-04-25 Pharmaceutical formulations
GB9408162A GB9408162D0 (en) 1994-04-25 1994-04-25 Pharmaceutical formulations
GB9408163.5 1994-04-25

Publications (2)

Publication Number Publication Date
KR970702723A true KR970702723A (ko) 1997-06-10
KR100363604B1 KR100363604B1 (ko) 2003-04-11

Family

ID=27451150

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960706126A KR100363604B1 (ko) 1994-04-25 1995-04-22 베타-락탐항생물질과함께베타-락타마제억제페넴을함유하는약제제형및이것의세균감염의치료에서의용도

Country Status (17)

Country Link
US (3) US5911985A (ko)
EP (1) EP0758240B1 (ko)
JP (2) JP3865770B2 (ko)
KR (1) KR100363604B1 (ko)
CN (1) CN1094353C (ko)
AT (1) ATE252906T1 (ko)
AU (1) AU690685B2 (ko)
BR (1) BR9507521A (ko)
CZ (1) CZ286898B6 (ko)
DE (1) DE69532032T2 (ko)
ES (1) ES2206502T3 (ko)
HU (1) HUT76340A (ko)
MX (1) MX9605149A (ko)
NO (1) NO964500L (ko)
NZ (1) NZ285085A (ko)
PL (1) PL179415B1 (ko)
WO (1) WO1995028935A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
TW200716104A (en) * 2005-06-01 2007-05-01 Wyeth Corp Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
RU2008102912A (ru) * 2005-07-27 2009-09-10 Вайет (Us) Сочетание ингибиторов бетта-лактазмы бициклического 6-алкилиденпенема с бетта-лактанным антибиотиком: антибиотик широкого спектра
BRPI0613928A2 (pt) * 2005-07-27 2011-02-15 Wyeth Corp método para o tratamento de uma infecção ou doença bacteriana; composição; produto; e uso de cefepima ou de um sal farmaceuticamente aceitável da mesma e um composto de fórmula i ou um sal farmaceuticamente aceitável ou éster hidrolisável in vivo do mesmo
GT200600380A (es) * 2005-08-24 2007-03-29 Proceso para la preparacion de inhibidores de beta-lactamasa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
EP0018203B1 (en) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
EP0041768B1 (en) * 1980-04-24 1987-11-11 Beecham Group Plc Beta-lactam compounds, their preparation and use
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB8518422D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB8518421D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
EP0210613A3 (en) * 1985-07-27 1987-06-16 Sumitomo Metal Industries, Ltd. Method of gasifying solid carbonaceous materials and apparatus therefor
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds

Also Published As

Publication number Publication date
NO964500D0 (no) 1996-10-23
JPH09512260A (ja) 1997-12-09
WO1995028935A1 (en) 1995-11-02
US5776455A (en) 1998-07-07
BR9507521A (pt) 1997-09-16
CZ315696A3 (en) 1997-06-11
HUT76340A (en) 1997-08-28
KR100363604B1 (ko) 2003-04-11
JP3865770B2 (ja) 2007-01-10
AU2407395A (en) 1995-11-16
CN1094353C (zh) 2002-11-20
AU690685B2 (en) 1998-04-30
US5939066A (en) 1999-08-17
EP0758240A1 (en) 1997-02-19
CN1149254A (zh) 1997-05-07
DE69532032T2 (de) 2004-07-22
EP0758240B1 (en) 2003-10-29
PL317045A1 (en) 1997-03-03
HU9602928D0 (en) 1996-12-30
MX9605149A (es) 1997-12-31
ES2206502T3 (es) 2004-05-16
ATE252906T1 (de) 2003-11-15
DE69532032D1 (de) 2003-12-04
NO964500L (no) 1996-11-26
NZ285085A (en) 1998-04-27
CZ286898B6 (en) 2000-07-12
PL179415B1 (pl) 2000-09-29
US5911985A (en) 1999-06-15
JP2005298525A (ja) 2005-10-27

Similar Documents

Publication Publication Date Title
MX9804107A (es) Derivados de quinolina.
AU1200695A (en) 4,5-diaryloxazole derivatives
DE69331089D1 (de) Beta-Laktam und Cepham Verbindungen und Ihre Herstellung
AU1962892A (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
KR970702723A (ko) 베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections)
HUP0001269A2 (hu) 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények
MX9803692A (es) Derivados de eritromicina triciclicos.
NZ308518A (en) Antibacterial cephalosporins
MY117265A (en) 6-(substituted methylene) penems and intermediates
ATE82976T1 (de) Cephalosporinderivate.
GB1456144A (en) Ureido-aryl cephalosporin compounds
ES2123756T3 (es) Derivados de piperazina.
BR9509889A (pt) Composto composição farmacêutica e processos para inibir beta-lactamases e para aumentar a atrividade biológica de um antibiótico do tipo beta-lactama
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
CA2188695A1 (en) Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
GB9326248D0 (en) Pharmaceutical formulations
NZ236413A (en) Cephalosporin derivatives and pharmaceutical compositions
KR900005050B1 (en) 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof
ES482550A1 (es) Un procedimiento para la produccion de derivados de cefalos-porina.
NZ218227A (en) Cephalosporin derivatives and pharmaceutical compositions
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
TW371304B (en) Cephem compounds having antibacterial activity, their production and pharmaceutical composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20081007

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee